A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

Recruiting

Phase 1

BMS-986460A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

Sponsor:

Bristol-Myers Squibb

Code:

NCT06877702

Conditions

Healthy Volunteers

Eligibility Criteria

Sex: Male

Age: 18 - 60

Healthy Volunteers: Accepted

Interventions

BMS-986460

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-05-15.